๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of fostedil, a new calcium antagonist, in beagle dogs following oral and intravenous administration

โœ Scribed by Elizabeth W. Thomas; Barbara A. Bopp


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
416 KB
Volume
73
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacokinetics of a new reversible pro
โœ Kye S. Han; Yoon G. Kim; Joong K. Yoo; Jong W. Lee; Myung G. Lee ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 175 KB ๐Ÿ‘ 1 views

The pharmacokinetics of YH1885 were evaluated after intravenous (iv) and oral administrations of the drug to rats and dogs. The reason for the low extent of bioavailability (F) of YH1885 after oral administration of the drug to rats and the absorption of the drug from various rat gastrointestinal (G

THE PHARMACOKINETICS OF 1954U89, 1, 3-DI
โœ S. D. STUDENBERG; J. L. WOOLLEY; D. V. DEANGELIS; W. A. WARGIN ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB ๐Ÿ‘ 1 views

1954U89, 1, 3-diamino-7-(1-ethylpropyl)-8-methyl-7H-pyrrolo-(3, 2-f )quinazoline, is a potent, lipid-soluble inhibitor of dihydrofolate reductase. The pharmacokinetics and bioavailability of 1954U89 were examined in male beagle dogs and male CD rats. Dogs received single intravenous (2ยด5 mg kg 71 )